If your email program has trouble displaying this email, view as a webpage.

Looking Back at NCTR's 2023 Accomplishments

 2023 NCTR Annual Report

The 2023 NCTR Annual Report illustrates the many ways NCTR continues to conduct integrated toxicological research, promote collaboration in the scientific community, and support risk-assessment needs related to public health. Some of NCTR’s 2023 accomplishments are highlighted below.

NCTR at White House Demo Day

Left to right: Dr. Qiang Shi, NCTR; Dr. Namandjé Bumpus, FDA Principal Deputy Commissioner (former FDA Chief Scientist); and Dr. David Strauss, CDER

In collaboration with FDA's Office of the Chief Scientist and the Center for Drug Evaluation and Research, Dr. Qiang Shi—scientist in NCTR's Division of Systems Biology—showcased organ-on-a-chip technology at American Possibilities: A White House Demo Day. More...

Select NCTR accomplishments from 2023 include:

• Researcher Inducted into ARA Academy of Scholars and Fellows

• 2022 EMGS Bioinformatics Challenge

• Retiree Receives "Distinguished Scientist Award"

• FDA Rare Disease Day Presentation

• NCTR-Led Bioinformatics Conference Features Opening Remarks from FDA's Chief Scientist

• NCTR Research on Inorganic Arsenic

• Publications Recognized by Scientific Journals in 2023

NCTR Presentations at FDA Grand Rounds in 2023

Several NCTR researchers presented at FDA Grand Rounds, "an educational presentation that is webcast monthly to highlight cutting-edge research underway across the Agency and its impact on protecting and advancing public health." Dr. Kristina Feye, microbiologist with the Division of Microbiology—FDA Grand Rounds, July 2023: The Plasmid Puzzle—Finding Solutions in Salmonella Dr. Angel Paredes, director of NCTR’s Electron Microscopy Core Facility—FDA Grand Rounds, May 2023: Electron Microscopy—Still a Powerful Research Tool Dr. Dayton Petibone, biologist with the Division of Genetic and Molecular Toxicology; and Dr. Qiang Shi, visiting scientist with the Division of Systems Biology—FDA Grand Rounds, March 2023: Microphysiological Systems as Novel Disease Models and Drug Development Tools

Please visit the links below to discover more!

Received this email from a friend or colleague? Subscribe here.